DE69426383D1 - Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu - Google Patents

Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu

Info

Publication number
DE69426383D1
DE69426383D1 DE69426383T DE69426383T DE69426383D1 DE 69426383 D1 DE69426383 D1 DE 69426383D1 DE 69426383 T DE69426383 T DE 69426383T DE 69426383 T DE69426383 T DE 69426383T DE 69426383 D1 DE69426383 D1 DE 69426383D1
Authority
DE
Germany
Prior art keywords
reactant
rheumatoid factor
determining
kit therefor
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426383T
Other languages
English (en)
Other versions
DE69426383T2 (de
Inventor
Yuji Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69426383D1 publication Critical patent/DE69426383D1/de
Publication of DE69426383T2 publication Critical patent/DE69426383T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69426383T 1993-11-19 1994-10-07 Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu Expired - Fee Related DE69426383T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29053793 1993-11-19

Publications (2)

Publication Number Publication Date
DE69426383D1 true DE69426383D1 (de) 2001-01-11
DE69426383T2 DE69426383T2 (de) 2001-09-27

Family

ID=17757313

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426383T Expired - Fee Related DE69426383T2 (de) 1993-11-19 1994-10-07 Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu

Country Status (5)

Country Link
EP (1) EP0662611B1 (de)
KR (1) KR950014137A (de)
AT (1) ATE197994T1 (de)
CA (1) CA2133772A1 (de)
DE (1) DE69426383T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220099A (ja) * 1995-02-10 1996-08-30 Morinaga Milk Ind Co Ltd 物質の検出試薬及び慢性関節リウマチの検知法
SE9602545L (sv) 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
DE10249608A1 (de) * 2002-10-18 2004-05-06 Gkss-Forschungszentrum Geesthacht Gmbh Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen
EP2037274A1 (de) * 2007-09-11 2009-03-18 GALAB Technologies GmbH Lektinbasierter Glykan-Assay
US9994605B2 (en) 2014-03-13 2018-06-12 Universitaet Basel Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein
US11091591B2 (en) 2015-09-16 2021-08-17 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63308561A (ja) * 1987-06-10 1988-12-15 Naoyuki Taniguchi 抗原の測定法
GB8726271D0 (en) * 1987-11-10 1987-12-16 Univ London Protein glycosylation assay
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
JP2726500B2 (ja) * 1989-07-14 1998-03-11 学校法人藤田学園 アガラクトシルIgGおよび診断薬

Also Published As

Publication number Publication date
KR950014137A (ko) 1995-06-15
CA2133772A1 (en) 1995-05-20
DE69426383T2 (de) 2001-09-27
EP0662611B1 (de) 2000-12-06
EP0662611A3 (de) 1996-08-21
ATE197994T1 (de) 2000-12-15
EP0662611A2 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
ATE221202T1 (de) Bestimmungsverfahren mit oligomerisierten rezeptoren
NO976122L (no) AntiFasligandantistoffer og analysefremgangsmåte hvor disse anvendes
AU4768490A (en) Diagnostic test using chimeric antibodies
DE68905313D1 (de) Enzym-immunoassay zur messung des cyclosporin-a-spiegels in vollblut-proben.
EP0383313A3 (de) Reagenz für Immuntestverfahren und Kit dieses enhaltend
WO2001016184A3 (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
DE69426383D1 (de) Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
CA2045475A1 (en) Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
AU2640399A (en) Method for immunochemically assaying anti-hm1.24 antibody
ES2115750T3 (es) Ensayo de captura de proteinas de union.
ATE283490T1 (de) Cobalamintest
MY106963A (en) Agglutination assay.
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
EP0250119A3 (de) Atherosclerotischer anti-idiotypischer Antikörper, Immunotest und Reagenzien
NO873154L (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
AU8008487A (en) A method for determining the presence of substances of diagnostic relevance, in particular antibodies or antigens, by the ELISA method with photometric evaluation
EP0328372A3 (de) Verfahren zur Bestimmung von Antigenen
EP0248630A3 (de) Immuntest für atherosklerotisches Plaque-Antigen
IT8906606A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anticaseina bovina nel siero
DE3863270D1 (de) Immuntest.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI R&D MANAGEMENT CO., LTD., TOKYO, JP

8339 Ceased/non-payment of the annual fee